Drug Patent Expirations in February 2014

Drug Patent Expirations for February 2014

Tradename Applicant Generic Name Patent Number Patent Expiration
LEVEMIR INNOLET Novo Nordisk Inc insulin detemir recombinant 6,869,930 Feb 2, 2014
LEVEMIR PENFILL Novo Nordisk Inc insulin detemir recombinant 6,869,930 Feb 2, 2014
LEVEMIR Novo Nordisk Inc insulin detemir recombinant 6,011,007 Feb 2, 2014
LEVEMIR FLEXPEN Novo Nordisk Inc insulin detemir recombinant 6,011,007 Feb 2, 2014
LEVEMIR INNOLET Novo Nordisk Inc insulin detemir recombinant 6,011,007 Feb 2, 2014
LEVEMIR PENFILL Novo Nordisk Inc insulin detemir recombinant 6,011,007 Feb 2, 2014
LEVEMIR Novo Nordisk Inc insulin detemir recombinant 6,869,930 Feb 2, 2014
LEVEMIR FLEXPEN Novo Nordisk Inc insulin detemir recombinant 6,869,930 Feb 2, 2014
CEDAX Pernix Therap ceftibuten dihydrate 5,599,557 Feb 4, 2014
ELIGARD Tolmar Therap leuprolide acetate 5,599,552 Feb 4, 2014
TEMODAR Merck Sharp Dohme temozolomide 5,260,291*PED Feb 11, 2014
EXELON Novartis rivastigmine tartrate 5,602,176 Feb 11, 2014
HECTOROL Genzyme Corp doxercalciferol 5,602,116 Feb 11, 2014
EXELON Novartis rivastigmine 5,602,176 Feb 11, 2014
ARTHROTEC Gd Searle Llc diclofenac sodium; misoprostol 5,601,843 Feb 11, 2014
TRITEC Glaxosmithkline ranitidine bismuth citrate 5,601,848 Feb 11, 2014
NIASPAN Abbvie niacin 6,818,229 Feb 15, 2014
DUAC Stiefel benzoyl peroxide; clindamycin phosphate 5,466,446 Feb 16, 2014
GILENYA Novartis fingolimod 5,604,229 Feb 18, 2014
CETROTIDE Emd Serono Inc cetrorelix 7,605,121 Feb 22, 2014
CETROTIDE Emd Serono Inc cetrorelix 6,863,891 Feb 22, 2014
ALVESCO Takeda Gmbh ciclesonide 5,605,674 Feb 25, 2014
PROVENTIL-HFA 3m albuterol sulfate 5,605,674 Feb 25, 2014
IMAGENT Imcor Pharms Co dimyristoyl lecithin; perflexane 5,605,673 Feb 25, 2014
QVAR 80 Teva Branded Pharm beclomethasone dipropionate 5,605,674 Feb 25, 2014
QNASL Teva Branded Pharm beclomethasone dipropionate 5,605,674 Feb 25, 2014
PROAIR HFA Teva Branded Pharm albuterol sulfate 5,605,674 Feb 25, 2014
MYLOTARG Wyeth Pharms Inc gemtuzumab ozogamicin 5,606,040 Feb 25, 2014
QVAR 40 Teva Branded Pharm beclomethasone dipropionate 5,605,674 Feb 25, 2014
XOPENEX HFA Sunovion levalbuterol tartrate 5,605,674 Feb 25, 2014
ZETONNA Takeda Gmbh ciclesonide 5,605,674 Feb 25, 2014
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.

Comments are closed.